K2 Medical Research is a leading clinical research organization dedicated to advancing medical science and improving patient outcomes through innovative, high-quality clinical trials. Headquartered in Central Florida, K2 partners with global pharmaceutical, diagnostic, and medical device companies to conduct multi-phasic patient-centered research across a broad range of therapeutic areas, including neurology, metabolic disease, mental health, and vaccine development. Co-founded by Brandon Lenox, DO, MPH, and Sean Stanton, K2 Medical Research operates with a clear mission: to bring tomorrow’s treatments to today’s patients. The company’s success reflects a steadfast commitment to scientific integrity, compassionate care, and community engagement—ensuring that clinical research is both accessible and meaningful to the populations it serves. Powered by a rapidly growing network of state-of-the-art clinical research sites across three states and multiple markets, a world-class team of investigators, and a track record of operational excellence, K2 Medical Research is redefining standards in the clinical trial industry. From pioneering early-phase studies to supporting large-scale global programs, K2 Medical Research is proud to play a pivotal role in shaping the future of medicine and improving lives through discovery.